Korea South
Medical AI, Inc. is a cutting-edge startup specializing in AI-ECG Software as a Medical Device. Their main focus is on developing AI algorithms using ECG data to diagnose and predict various diseases, particularly heart failure and myocardial infarction.
The company, established in 2019, has made significant strides in the industry. Their software is already being utilized in over 50 hospitals, catering to more than 100,000 patients on a monthly basis. Notably, they have also kicked off their global expansion, venturing into markets in the U.S., India, and Europe.
Catering to the AI, Fintech, and Health Care industries, Medical AI, Inc. is carving out a niche for itself through its innovative approach to medical diagnostics and prediction using advanced technology.
While specific details about their last investment and investors aren't available at the moment, Medical AI, Inc. is certainly a startup to watch. With its groundbreaking technology and rapid expansion, it is poised to make waves in the medical AI space, offering potential opportunities for venture capital investors seeking innovative and high-growth prospects in the health tech sector.
